查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1673857

过敏治疗市场按类型、治疗方法、分销管道和地区划分

Allergy Treatment Market, By Type, By Treatment, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球过敏治疗市场规模估计为 227.6 亿美元，预计到 2032 年将达到 375.4 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 7.4%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 227.6亿美元
效能资料 2020-2024 预测期 2025-2032
预测期：2025 年至 2032 年复合年增长率 7.40％ 2032 年金额预测 375.4亿美元
数字。 2025 年过敏治疗市场占有率（按地区划分）
过敏治疗市场-IMG1

由于全球过敏性疾病的发生率不断上升，全球过敏治疗市场在过去几年中经历了显着增长。过敏性疾病是由免疫系统对灰尘、花粉和霉菌等环境过敏原过度反应引起的。最近的估计表明，全世界有超过 10 亿人患有过敏性鼻炎。此外，污染程度的加剧和生活方式的改变进一步增加了过敏的风险。因此，对有效治疗方案以控制各种过敏症状的需求日益增加，包括抗组织胺、减充血剂、皮质类固醇和过敏原免疫疗法。

市场动态

全球过敏治疗市场受到污染水平上升、气候条件变化以及新兴经济体医疗保健支出增加等因素的推动。然而，农村地区对过敏治疗认知度低以及免疫治疗成本高阻碍了市场的成长。开发疗效较佳的新型治疗方法为市场带来了丰厚的机会。主要企业正致力于研发先进的治疗方法，以解决抗药性问题。然而，有关新型过敏治疗方法的核准的严格规定带来了挑战。

研究的主要特点

  • 本报告对全球过敏治疗市场进行了详细分析，并展示了预测期（2025-2032 年）的市场规模（以十亿美元计）和年复合成长率（CAGR%），以 2024 年为基准年。
  • 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 全球过敏治疗市场的主要企业是根据公司亮点、产品系列、关键亮点、业绩和策略等参数进行介绍的。
  • 主要企业包括赛诺菲、诺华、葛兰素史克公司、强生服务公司、罗氏公司、Stallergenes Greer、Dermapharm Holding SE、Nicox、Allergy Therapeutics、艾伯维公司、梯瓦製药工业有限公司、Alembic Pharmaceuticals Limited、ALK-Abello A/S、EU​​lanator A/SEN​​U​​S A世。
  • 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球过敏治疗市场迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过全球过敏治疗市场分析中使用的各种策略矩阵轻鬆做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 流行病学
  • 监管情景
  • 製造商收益
  • 收购和合作场景
  • 产品发布/核准
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

4. 全球过敏治疗市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020 年至 2032 年全球过敏治疗市场（按类型划分）（十亿美元）

  • 介绍
  • 眼睛过敏
  • 气喘
  • 鼻炎
  • 皮肤过敏
  • 食物过敏
  • 其他的

6. 全球过敏治疗市场，依治疗方法，2020-2032 年（十亿美元）

  • 介绍
  • 抗过敏药物
  • 免疫疗法

7. 2020 年至 2032 年全球过敏治疗市场按分销管道划分（十亿美元）

  • 介绍
  • 医院药房
  • 零售药局
  • 网路药局

8. 2020 年至 2032 年全球过敏治疗市场（按地区划分）（十亿美元）

  • 介绍
  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章 竞争格局

  • 公司简介
    • Sanofi
    • Novartis
    • GSK plc
    • Johnson & Johnson Services, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Stallergenes Greer
    • Dermapharm Holding SE
    • Nicox
    • Allergy Therapeutics
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • ALK-Abello A/S
    • Bausch Health Companies Inc.
    • GLENMARK PHARMACEUTICALS LTD.
    • Perrigo Company plc
    • Dr Reddy's Laboratories Ltd.

第 10 章 分析师观点

  • 兴衰
  • 一致的机会地图

第 11 章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI5143

Global Allergy Treatment Market is estimated to be valued at USD 22.76 Bn in 2025 and is expected to reach USD 37.54 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 22.76 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.40% 2032 Value Projection: USD 37.54 Bn
Figure. Allergy Treatment Market Share (%), By Region 2025
Allergy Treatment Market - IMG1

The global allergy treatment market has been witnessing significant growth over the past few years owing to the rising prevalence of allergic disorders worldwide. Allergic disorders are caused when the immune system overreacts to environmental allergens such as dust, pollen, mold, etc. According to recent estimates, over 1 billion people globally suffer from allergic rhinitis. Additionally, the rising levels of pollution and changed lifestyle habits have further increased the risk of developing allergies. As a result, there has been a growing demand for effective treatment options such as antihistamines, decongestants, corticosteroids, and allergen immunotherapy for managing the symptoms of various allergic conditions.

Market Dynamics:

The global allergy treatment market is driven by factors such as increasing pollution levels, changing climate conditions, and rising healthcare expenditure in developing nations. However, the lack of awareness about allergy treatment in rural areas and high costs associated with immunotherapy restrain the market growth. The development of novel therapeutic drugs with improved efficacy offers lucrative opportunities in the market. Key players are focusing on R&D to develop advanced treatment regimens for tackling drug resistance issues. However, stringent regulations for approval of new allergy drugs pose a challenge

Key Features of the Study:

  • This report provides an in-depth analysis of the global allergy treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global allergy treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Sanofi, Novartis, GSK plc, Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Stallergenes Greer, Dermapharm Holding SE, Nicox, Allergy Therapeutics, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, ALK-Abello A/S, Bausch Health Companies Inc., GLENMARK PHARMACEUTICALS LTD., Perrigo Company plc, and Dr Reddy's Laboratories Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global allergy treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy treatment market.

Detailed Segmentation-

  • By Type:
    • Eye Allergy
    • Asthma
    • Rhinitis
    • Skin Allergy
    • Food Allergies
    • Others
  • By Treatment:
    • Anti-allergy Drugs
    • Immunotherapy
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Sanofi
    • Novartis
    • GSK plc
    • Johnson & Johnson Services, Inc.
    • Hoffmann-La Roche Ltd.
    • Stallergenes Greer
    • Dermapharm Holding SE
    • Nicox
    • Allergy Therapeutics
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • ALK-Abello A/S
    • Bausch Health Companies Inc.
    • GLENMARK PHARMACEUTICALS LTD.
    • Perrigo Company plc
    • Dr Reddy's Laboratories Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Treatment
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Epidemiology
  • Regulatory Scenario
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Allergy Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Allergy Treatment Market, By Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Eye Allergy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Asthma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Rhinitis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Skin Allergy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Food Allergies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Allergy Treatment Market, By Treatment, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Anti-allergy Drugs
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Immunotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Allergy Treatment Market, By Distribution Channel, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Allergy Treatment Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Sanofi
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novartis
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GSK plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Johnson & Johnson Services, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • F. Hoffmann-La Roche Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Stallergenes Greer
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Dermapharm Holding SE
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nicox
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Allergy Therapeutics
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Alembic Pharmaceuticals Limited
    • ALK-Abello A/S
    • Bausch Health Companies Inc.
    • GLENMARK PHARMACEUTICALS LTD.
    • Perrigo Company plc
    • Dr Reddy's Laboratories Ltd.

10. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact